<SEC-DOCUMENT>0001193125-22-066277-index.html : 20220304
<SEC-HEADER>0001193125-22-066277.hdr.sgml : 20220304
<ACCEPTANCE-DATETIME>20220304170332
ACCESSION NUMBER:		0001193125-22-066277
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20220304
DATE AS OF CHANGE:		20220304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251022
		FILM NUMBER:		22715077

	BUSINESS ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d251573d424b5.htm
<DESCRIPTION>424B5
<TEXT>
Document 1 - file: d251573d424b5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d251573dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: d251573dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g251573g01a17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: g251573g01a17.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g251573g60d80.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g251573g60d80.jpg

</DOCUMENT>
</SEC-DOCUMENT>